BRIEF-Gilead Sciences Canada says Ontario to list Epclusa on public drug plan to treat all six genotypes of chronic Hepatitis C infection

* Gilead Sciences Canada- effective feb 28, ontario to list epclusa on public drug plan to treat all six genotypes of chronic hepatitis c infection Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.